Mojtaba Lotfi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mojtaba Lotfi has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Mehrnaz Nazari Rad
Clinical Research Development Unit, Akbar Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
4 shared publications - Jalal Nourmohammadi
Student Research Committee, Faculty of Nursing and Midwifery, Zahedan University of Medical Sciences, Zahedan, Iran
3 shared publications - Ali Khajeh
Children and Adolescent Health Research Center, Resistant Tuberculosis Institute, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
2 shared publications - Behrouz Khajeh
Children and Adolescent Health Research Center, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
2 shared publications - Ameneh Sheikh
Research Committee of the Nursing and Midwifery, Zabol University of Medical Sciences, Zabol, Iran
1 shared publication - Amirhossein Khoshghadam
Department of Occupational Health, Tehran Islamic Azad University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 11 August 2026
- Published by Brieflands in International Journal of Endocrinology and Metabolism
- Vol. 25 (1) , e169084
Artificial Intelligence-Driven Digital Tools for Diabetes Self-management in Children: A Scoping Review
Context: Managing diabetes in children is challenging and requires continuous monitoring and structured self-care support. Artificial intelligence (AI)-driven digital tools may enhance self-management and improve health outcomes. This scoping review aimed to synthesize the existing evidence on AI-driven digital tools for pediatric diabetes self-management, focusing on their functionalities, benefits, and limitations. Evidence Acquisition: From an initial pool of 97 articles published between January 2010 and March 1, 2025, 19 studies met the predefined inclusion criteria. A systematic search was conducted in PubMed, Scopus, Web of Science, CINAHL, PsycINFO, and Embase using predefined keywords. Two independent reviewers performed screening and data extraction. Methodological quality was appraised using the Cochrane Risk of Bias Tool, the Newcastle-Ottawa Scale, and the Critical Appraisal Skills Programme (CASP) Checklist. Qualitative and quantitative findings were synthesized thematically. Results: The 19 included studies addressed several overlapping application domains of AI-driven digital tools for pediatric diabetes self-management. Overall, 8 studies focused primarily on glucose prediction, glycemic monitoring, or pattern recognition; 4 studies evaluated insulin dosing optimization and clinical decision-support systems; 6 studies investigated personalized education, behavioral support, user engagement, or self-management learning interventions; 5 studies examined telemedicine, remote monitoring, or healthcare access; and 5 studies primarily addressed ethical, methodological, transparency, or implementation challenges. Discussion: AI-based digital tools have considerable potential to support diabetes self-management in children. Future research should prioritize long-term evaluations, the inclusion of diverse populations, and rigorous assessments of clinical outcomes, data privacy, and algorithm performance.
- 11 August 2026
- Published by Brieflands in International Journal of Endocrinology and Metabolism
- Vol. 25 (1) , e169084
Open AccessArtificial Intelligence-Driven Digital Tools for Diabetes Self-management in Children: A Scoping Review
Context: Managing diabetes in children is challenging and requires continuous monitoring and structured self-care support. Artificial intelligence (AI)-driven digital tools may enhance self-management and improve health outcomes. This scoping review aimed to synthesize the existing evidence on AI-driven digital tools for pediatric diabetes self-management, focusing on their functionalities, benefits, and limitations. Evidence Acquisition: From an initial pool of 97 articles published between January 2010 and March 1, 2025, 19 studies met the predefined inclusion criteria. A systematic search was conducted in PubMed, Scopus, Web of Science, CINAHL, PsycINFO, and Embase using predefined keywords. Two independent reviewers performed screening and data extraction. Methodological quality was appraised using the Cochrane Risk of Bias Tool, the Newcastle-Ottawa Scale, and the Critical Appraisal Skills Programme (CASP) Checklist. Qualitative and quantitative findings were synthesized thematically. Results: The 19 included studies addressed several overlapping application domains of AI-driven digital tools for pediatric diabetes self-management. Overall, 8 studies focused primarily on glucose prediction, glycemic monitoring, or pattern recognition; 4 studies evaluated insulin dosing optimization and clinical decision-support systems; 6 studies investigated personalized education, behavioral support, user engagement, or self-management learning interventions; 5 studies examined telemedicine, remote monitoring, or healthcare access; and 5 studies primarily addressed ethical, methodological, transparency, or implementation challenges. Discussion: AI-based digital tools have considerable potential to support diabetes self-management in children. Future research should prioritize long-term evaluations, the inclusion of diverse populations, and rigorous assessments of clinical outcomes, data privacy, and algorithm performance.
- Open Access
- 31 July 2026
- Published by Brieflands in Jundishapur Journal of Chronic Disease Care
- Vol. 15 (3) , e172751
Sex Distribution and Epidemiological Patterns in Febrile Seizures: A Systematic Review
Context: Febrile seizures are the most common seizure disorder in early childhood and are a major cause of emergency department visits and parental anxiety. Although numerous epidemiological studies have reported sex differences among affected children, the consistency of these findings across diverse populations remains uncertain. A comprehensive synthesis of the available evidence is therefore needed to clarify sex-related epidemiological patterns in febrile seizures. This systematic review aimed to synthesize published evidence on sex distribution and epidemiological patterns among children with febrile seizures across diverse populations. Evidence Acquisition: This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Five electronic databases (PubMed, Scopus, Web of Science, Embase, and the Cochrane Library) were searched from inception to January 2026. Observational studies reporting sex distribution or epidemiological characteristics of children with febrile seizures were eligible for inclusion. Two reviewers independently conducted study selection, data extraction, and quality assessment. Extracted data included study characteristics, sample size, age, sex distribution, and key epidemiological findings. Results: Fifteen studies involving children with febrile seizures were included. In most studies, boys accounted for a higher proportion of affected children than girls, although reported male-to-female ratios varied considerably across populations. Sex distributions differed by geographic region and study setting, indicating substantial epidemiological heterogeneity. Several studies also reported variation in age at presentation, family history, fever characteristics, seizure type, recurrence patterns, and associated clinical factors. However, the available evidence was largely descriptive and did not consistently evaluate sex after adjustment for potential confounding variables. Discussion: Current evidence indicates that febrile seizures are more frequently reported in boys across many study populations, although the magnitude of this difference varies across epidemiological settings. The existing literature primarily describes the sex distribution rather than establishing biological sex as an independent determinant of febrile seizures. Future large-scale prospective studies using standardized methodologies and multivariable analyses are warranted to clarify sex-related epidemiological patterns and their potential clinical implications.
- 31 July 2026
- Published by Brieflands in Jundishapur Journal of Chronic Disease Care
- Vol. 15 (3) , e172751
Open AccessSex Distribution and Epidemiological Patterns in Febrile Seizures: A Systematic Review
Context: Febrile seizures are the most common seizure disorder in early childhood and are a major cause of emergency department visits and parental anxiety. Although numerous epidemiological studies have reported sex differences among affected children, the consistency of these findings across diverse populations remains uncertain. A comprehensive synthesis of the available evidence is therefore needed to clarify sex-related epidemiological patterns in febrile seizures. This systematic review aimed to synthesize published evidence on sex distribution and epidemiological patterns among children with febrile seizures across diverse populations. Evidence Acquisition: This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Five electronic databases (PubMed, Scopus, Web of Science, Embase, and the Cochrane Library) were searched from inception to January 2026. Observational studies reporting sex distribution or epidemiological characteristics of children with febrile seizures were eligible for inclusion. Two reviewers independently conducted study selection, data extraction, and quality assessment. Extracted data included study characteristics, sample size, age, sex distribution, and key epidemiological findings. Results: Fifteen studies involving children with febrile seizures were included. In most studies, boys accounted for a higher proportion of affected children than girls, although reported male-to-female ratios varied considerably across populations. Sex distributions differed by geographic region and study setting, indicating substantial epidemiological heterogeneity. Several studies also reported variation in age at presentation, family history, fever characteristics, seizure type, recurrence patterns, and associated clinical factors. However, the available evidence was largely descriptive and did not consistently evaluate sex after adjustment for potential confounding variables. Discussion: Current evidence indicates that febrile seizures are more frequently reported in boys across many study populations, although the magnitude of this difference varies across epidemiological settings. The existing literature primarily describes the sex distribution rather than establishing biological sex as an independent determinant of febrile seizures. Future large-scale prospective studies using standardized methodologies and multivariable analyses are warranted to clarify sex-related epidemiological patterns and their potential clinical implications.
- Open Access
- 31 May 2026
- Published by Brieflands in Journal of Comprehensive Pediatrics
- Vol. 17 (2) , e173345
Socioeconomic Status and Cerebral Palsy Outcomes in Children: A Systematic Review
Context: Cerebral palsy (CP) is the leading cause of lifelong physical disability in childhood. Increasing evidence suggests that socioeconomic status (SES) may influence the risk of CP through multiple biological, environmental, and healthcare-related pathways. However, findings remain inconsistent because studies have used diverse socioeconomic indicators, methodological approaches, and analytical strategies. This systematic review synthesized contemporary evidence on the association between socioeconomic status and the risk of CP in children. Evidence Acquisition: This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020) guidelines. We conducted a comprehensive literature search in PubMed, Scopus, Web of Science, Embase, and Google Scholar for studies published between January 2010 and January 2026. We included observational and population-based studies examining the association between individual- or area-level socioeconomic status and the risk of cerebral palsy (CP) in children. Two reviewers independently extracted data, assessed study quality using validated appraisal tools, and synthesized the findings narratively due to methodological heterogeneity. Results: Twelve studies from Europe, North America, and Asia consistently showed that socioeconomic disadvantage was associated with a higher risk or prevalence of cerebral palsy (CP). Parental education and area-level deprivation were the strongest and most consistent predictors, whereas evidence for household income was less consistent. Socioeconomic disadvantage was also associated with more severe neurological impairment, and these associations often persisted after adjustment for perinatal factors, suggesting an independent contribution of SES to CP risk. Discussion: Current evidence indicates that socioeconomic disadvantage is associated with a higher risk and greater clinical severity of cerebral palsy (CP). Socioeconomic status likely influences CP through multiple biological, healthcare, and social pathways, rather than serving solely as a demographic characteristic. Reducing disparities in CP will require both improved maternal and neonatal care and policies that address social inequalities. Future studies should use standardized measures of socioeconomic status to better clarify causal pathways and inform prevention strategies.
- 31 May 2026
- Published by Brieflands in Journal of Comprehensive Pediatrics
- Vol. 17 (2) , e173345
Open AccessSocioeconomic Status and Cerebral Palsy Outcomes in Children: A Systematic Review
Context: Cerebral palsy (CP) is the leading cause of lifelong physical disability in childhood. Increasing evidence suggests that socioeconomic status (SES) may influence the risk of CP through multiple biological, environmental, and healthcare-related pathways. However, findings remain inconsistent because studies have used diverse socioeconomic indicators, methodological approaches, and analytical strategies. This systematic review synthesized contemporary evidence on the association between socioeconomic status and the risk of CP in children. Evidence Acquisition: This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020) guidelines. We conducted a comprehensive literature search in PubMed, Scopus, Web of Science, Embase, and Google Scholar for studies published between January 2010 and January 2026. We included observational and population-based studies examining the association between individual- or area-level socioeconomic status and the risk of cerebral palsy (CP) in children. Two reviewers independently extracted data, assessed study quality using validated appraisal tools, and synthesized the findings narratively due to methodological heterogeneity. Results: Twelve studies from Europe, North America, and Asia consistently showed that socioeconomic disadvantage was associated with a higher risk or prevalence of cerebral palsy (CP). Parental education and area-level deprivation were the strongest and most consistent predictors, whereas evidence for household income was less consistent. Socioeconomic disadvantage was also associated with more severe neurological impairment, and these associations often persisted after adjustment for perinatal factors, suggesting an independent contribution of SES to CP risk. Discussion: Current evidence indicates that socioeconomic disadvantage is associated with a higher risk and greater clinical severity of cerebral palsy (CP). Socioeconomic status likely influences CP through multiple biological, healthcare, and social pathways, rather than serving solely as a demographic characteristic. Reducing disparities in CP will require both improved maternal and neonatal care and policies that address social inequalities. Future studies should use standardized measures of socioeconomic status to better clarify causal pathways and inform prevention strategies.
- Open Access
- 1 June 2025
- Published by Maad Rayan Publishing Company in Journal of Parathyroid Disease
- Vol. 13 (1) , e13293
Association between glucagon-like peptide-1 receptor agonists and thyroid carcinoma; a systematic review and meta-analysis of observational studies
Introduction: Glucagon-like peptide-1 receptor agonists (GLP1-RAs) are drugs administered to treat type 2 diabetes mellitus; however, their relationship with thyroid cancer is still unclear. Hence, the present study aimed to examine the association between the use of GLP1-RA and thyroid carcinoma. Materials and Methods: Databases searched—including Web of Science, Cochrane, Scopus, ProQuest, PubMed, Embase, and Google Scholar—were searched without a time limit until May 1, 2025. Data were entered into SPSS 19 and analyzed using STATA 14. Tests with P values less than 0.05 were considered statistically significant (P < 0.05). Results: The relationship between GLP1-RA and thyroid carcinoma based on hazard ratio (HR: 1.14, 95% CI: 0.86, 1.51) and incidence rate ratio (IRR: 1.32, 95% CI: 0.79, 2.20) was statistically insignificant. However, according to odds ratio (OR), use of GLP1-RA increased the risk of thyroid cancer (OR: 1.46, 95% CI: 1.23, 1.74). Furthermore, the association between GLP1-RA and medullary thyroid carcinoma was insignificant (HR: 1.51, 95% CI: 0.90, 2.54). The relationship between GLP1-RA and thyroid carcinoma among women (HR: 1.01, 95% CI: 0.69, 1.47), men (HR: 0.72, 95% CI: 0.33, 1.57), individuals aged 50 to 59 (HR: 1.30, 95% CI: 0.96, 1.75), 60 to 69 (HR: 0.95, 95% CI: 0.65, 1.38), in China (HR: 1.26, 95% CI: 0.91, 1.76), France (HR: 3.43, 95% CI: 1.30, 9.04), and Korea (HR: 1.05, 95% CI: 0.76, 1.46) was statistically insignificant. However, in the USA (HR: 1.44, 95% CI: 1.22, 1.71), GLP1-RA administration increased the risk of thyroid neoplasm. Conclusion: Generally, the relationship between the GLP1-RA use in patients with type 2 diabetes mellitus and the risk of thyroid carcinoma was insignificant. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO (ID: CRD420251051827) and Research Registry (reviewregistry1993) websites.
- 1 June 2025
- Published by Maad Rayan Publishing Company in Journal of Parathyroid Disease
- Vol. 13 (1) , e13293
Open AccessAssociation between glucagon-like peptide-1 receptor agonists and thyroid carcinoma; a systematic review and meta-analysis of observational studies
Introduction: Glucagon-like peptide-1 receptor agonists (GLP1-RAs) are drugs administered to treat type 2 diabetes mellitus; however, their relationship with thyroid cancer is still unclear. Hence, the present study aimed to examine the association between the use of GLP1-RA and thyroid carcinoma. Materials and Methods: Databases searched—including Web of Science, Cochrane, Scopus, ProQuest, PubMed, Embase, and Google Scholar—were searched without a time limit until May 1, 2025. Data were entered into SPSS 19 and analyzed using STATA 14. Tests with P values less than 0.05 were considered statistically significant (P < 0.05). Results: The relationship between GLP1-RA and thyroid carcinoma based on hazard ratio (HR: 1.14, 95% CI: 0.86, 1.51) and incidence rate ratio (IRR: 1.32, 95% CI: 0.79, 2.20) was statistically insignificant. However, according to odds ratio (OR), use of GLP1-RA increased the risk of thyroid cancer (OR: 1.46, 95% CI: 1.23, 1.74). Furthermore, the association between GLP1-RA and medullary thyroid carcinoma was insignificant (HR: 1.51, 95% CI: 0.90, 2.54). The relationship between GLP1-RA and thyroid carcinoma among women (HR: 1.01, 95% CI: 0.69, 1.47), men (HR: 0.72, 95% CI: 0.33, 1.57), individuals aged 50 to 59 (HR: 1.30, 95% CI: 0.96, 1.75), 60 to 69 (HR: 0.95, 95% CI: 0.65, 1.38), in China (HR: 1.26, 95% CI: 0.91, 1.76), France (HR: 3.43, 95% CI: 1.30, 9.04), and Korea (HR: 1.05, 95% CI: 0.76, 1.46) was statistically insignificant. However, in the USA (HR: 1.44, 95% CI: 1.22, 1.71), GLP1-RA administration increased the risk of thyroid neoplasm. Conclusion: Generally, the relationship between the GLP1-RA use in patients with type 2 diabetes mellitus and the risk of thyroid carcinoma was insignificant. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO (ID: CRD420251051827) and Research Registry (reviewregistry1993) websites.
- Open Access
- 15 April 2025
- Published by Maad Rayan Publishing Company in Journal of Parathyroid Disease
- Vol. 13 (1) , e13289
Mobile radiation’s impact on thyroid health-focused on pediatric population; a review of literature
Since evidence suggesting a direct link between mobile phone radiation and thyroid cancer is not conclusive, emerging studies indicate its biological effects on thyroid function among heavy users. The impact of mobile radiation on pediatric thyroid health warrants serious consideration as mobile technology becomes increasingly pervasive in children’s lives. The unique anatomical and physiological vulnerabilities present in children make them particularly susceptible to potential adverse effects from radio frequency electromagnetic radiation. Studies indicate a possible association between mobile radiation exposure and thyroid dysfunction. The complexity of interactions between mobile radiation, individual genetic backgrounds, and persistent health outcomes still needs several studies.
- 15 April 2025
- Published by Maad Rayan Publishing Company in Journal of Parathyroid Disease
- Vol. 13 (1) , e13289
Open AccessMobile radiation’s impact on thyroid health-focused on pediatric population; a review of literature
Since evidence suggesting a direct link between mobile phone radiation and thyroid cancer is not conclusive, emerging studies indicate its biological effects on thyroid function among heavy users. The impact of mobile radiation on pediatric thyroid health warrants serious consideration as mobile technology becomes increasingly pervasive in children’s lives. The unique anatomical and physiological vulnerabilities present in children make them particularly susceptible to potential adverse effects from radio frequency electromagnetic radiation. Studies indicate a possible association between mobile radiation exposure and thyroid dysfunction. The complexity of interactions between mobile radiation, individual genetic backgrounds, and persistent health outcomes still needs several studies.
- Open Access
- 17 September 2021
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 75 (12) , e14883
Dietary insulin index and load with risk of breast cancer in a case‐control study
Objective Circulating insulin levels have been positively associated with risk of breast cancer (BrCa); however, it remains unclear whether a diet inducing an elevated insulin response influences Breast risk. Methods In this study, 250 newly diagnosed breast cancer patients and 250 hospitalized controls were recruited using convenience sampling. The dietary insulin index (DII) was calculated by dividing the dietary insulin load by the total energy intake. Results Compared with those in the lowest tertiles of DII and dietary insulin load (DIL), subjects in the highest tertile were more likely to be overweight, have a family history of breast and other types of cancer and a history of benign breast diseases. After controlling for multiple potential confounders, a significantly increased BrCa odds was observed in the highest tertiles of DII and DIL score compared to the lowest tertiles (odds ratio (OR): 1.46; 95% CI: 0.67–3.19, p = 0.006) and (OR: 1.87; 95% CI: 0.92–3.80, p = 0.038), respectively. Conclusions Our findings suggest that a diet that induces an elevated postprandial insulin response, indicated by higher DII and DIL scores, may increase the odds of BrCa, especially among women.
- 17 September 2021
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 75 (12) , e14883
Open AccessDietary insulin index and load with risk of breast cancer in a case‐control study
Objective Circulating insulin levels have been positively associated with risk of breast cancer (BrCa); however, it remains unclear whether a diet inducing an elevated insulin response influences Breast risk. Methods In this study, 250 newly diagnosed breast cancer patients and 250 hospitalized controls were recruited using convenience sampling. The dietary insulin index (DII) was calculated by dividing the dietary insulin load by the total energy intake. Results Compared with those in the lowest tertiles of DII and dietary insulin load (DIL), subjects in the highest tertile were more likely to be overweight, have a family history of breast and other types of cancer and a history of benign breast diseases. After controlling for multiple potential confounders, a significantly increased BrCa odds was observed in the highest tertiles of DII and DIL score compared to the lowest tertiles (odds ratio (OR): 1.46; 95% CI: 0.67–3.19, p = 0.006) and (OR: 1.87; 95% CI: 0.92–3.80, p = 0.038), respectively. Conclusions Our findings suggest that a diet that induces an elevated postprandial insulin response, indicated by higher DII and DIL scores, may increase the odds of BrCa, especially among women.